,

Standardby Admin0 Comments

The incubator-cum-accelerator, XHealth Innovation Lab, has been set up with an initial corpus of $50 million (nearly Rs 380 crore) for which investors have already given commitment for 60 percent of the funding, according to a source involved in the venture. https://www.moneycontrol.com/news/business/aster-dm-healthcare-lsv-capital-set-up-health-tech-incubator-with-50-million-corpus-5303861.html

0
, ,

Standardby Admin0 Comments

Recently Defence Research and Development Organisation (DRDO) has listed 35 (approximately 13 major items) technologies related to COVID-19 pandemic for manufacturing, marketing and sale as per the specifications mentioned on its website. https://www.financialexpress.com/defence/drdo-covid-technology-transfer-for-msme-manufacturing-know-more-about-the-terms-conditions/1967656/

0
,

Standardby Admin0 Comments

The Bengaluru-based company has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country, Strides Founder and Non-Executive Chairman Arun Kumar said on a post-earnings conference call, without giving any more details. Read more at: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-to-conduct-trials-in-india-for-potential-covid-19-drug/articleshow/75860443.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

0
,

Standardby Vinit Deo0 Comments

The partnership would enable free-of-cost testing for COVID-19 to a large number of people from disadvantaged and marginalised communities, using NCBS-TIFR and inStem’s high-capacity technical capabilities and skilled scientific personnel, an Azim Premji Foundation statement said. Read more at: https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/azim-premji-foundation-ncbs-instem-ink-partnership-on-enhanced-testing-for-covid-19/articleshow/75803317.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

0